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Abstract

Immunizations are one of the most important developments in the twentieth century
towards the prevention of infectious diseases. Vaccinations against communicable diseases have
helped reduce morbidity and mortality all over the world. Despite having numerous vaccines that
protect individuals from serious and deadly diseases, vaccination rates in the United States
remain at an all-time low. The Information and Education section of the Immunization Branch
within the Division of Communicable Disease Control at the California Department of Public
Health (CDPH) focuses on working with local health departments, primary care providers,
immunization coalitions, and other statewide organizations to increase the rates of vaccinations
in the United States. The Information and Education section aims to address vaccination
disparities in the state of California. The main reasons parents and guardians opt out of fully
vaccinating their children are due to personal belief exemptions (PBEs), concerns regarding
vaccine-related side effects, and low provider recommendation. The Information and Education
section is in charge of creating statewide campaigns and educational materials to help increase
immunization rates. Four goals were developed for this fieldwork experience: general
familiarization with the Immunization Branch; participate in the planning of Preteen Vaccine
Week Campaign 2015, an immunization informing campaign; conduct impact evaluation and
education material; and participate in maintenance of other immunization informing campaigns.
The following paper is a summary of a 300-hour fieldwork experience at the CDPH to help
increase awareness of vaccine-preventable diseases and the importance of being fully immunized
through the development of informational and educational materials.
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Prevention of Vaccine-Preventable Diseases through Information and Education at the California
Department of Public Health
The increase in life expectancy in the twentieth century is predominantly due to the
development of vaccinations. Vaccines have helped reduce mortality and disability due to
infectious disease. Even though vaccinations go through numerous research and study trials,
vaccination rates remain low (United States Department of Health and Human Services [HHS],
Healthy People 2020, 2014). People in the United States continue getting diseases that are
vaccine preventable.
Roughly speaking, 42,000 adults and 300 children die in the United States annually from
vaccine-preventable diseases (Centers for Disease Control and Prevention [CDC], 1999).
Communities with unvaccinated and under-vaccinated residents are at greater risks for outbreaks
of vaccine-preventable diseases (HHS, Healthy People 2020, 2014). For example, on average,
200,000 hospitalizations and 36,000 deaths occur annually in the United States due to influenza
(CDC, 2011). The goal of public health professionals is to concentrate on decreasing the rates of
hospitalization and deaths due to vaccine-preventable diseases.
Currently, there are 17 vaccine-preventable diseases vaccinations (HHS, Healthy People
2020, 2014). Even though diseases, such as polio, have been eradicated in the United States, does
not mean children should not be vaccinated against it. All infectious diseases are only a plane
ride away. A recent example is the rise of measles in the United States. Measles is a highly
contagious respiratory disease caused by a virus. Measles can spread through the air by coughing
or sneezing and can lead to a fever, sore throat, and rash covering the body (CDC, 2014a). The
rates of measles in the United States had been low since the endemic was eradicated in 2000
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(Orenstein, Papania & Wharton, 2004); unfortunately, measles cases have been on the rise.
Currently, the CDC (2014a) has confirmed 603 cases of measles and 20 outbreaks this past year
– the most number of confirmed cases since 1994. Measles can spread when members of
communities are not vaccinated.
The best way for populations to be protected against infectious diseases is to be fully
vaccinated. However, more and more individuals are choosing not to vaccinate themselves or
their children due to personal belief exemptions (PBEs), fear of side effects, and low rates of
provider recommendations.
Background
There was a time when families could not afford vaccines. In the early 1990s, racial and
ethnic minority children were at a greater risk for measles (Walker, Smith & Kolasa, 2014). In
order to address the gaps of vaccination coverage, the Vaccines for Children (VFC) Program was
established in 1994 (The Childhood Immunization Initiative, 2000). VFC is a program managed
by the CDC and has provided vaccines to children at no cost who might not be vaccinated due to
their inability to pay (Walker, Smith & Kolasa, 2014). Disparities in vaccination coverage
amongst racial and ethnic minorities have declined; the VFC program continues to provide
access to vaccinations to protect all children in the United States from vaccine-preventable
diseases (Walker, Smith & Kolasa, 2014).
In the 1980s, children were not vaccinated because parents and guardians could not
afford the cost of vaccines. Today, many affluent parents and guardians are refusing to vaccinate
their children in the state of California (Khazan, 2014). Parents and guardians are submitting
PBE forms to schools and opting out of vaccinating their child because the vaccines are against
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their personal beliefs (Allen-Price & Aliferis, 2014). PBE rates have doubled in the last 7 years
in the state of California (Allen-Price & Aliferis, 2014). This leads to elite counties such as
Marin, Los Angeles, Santa Monica, and Beverly Hills, to have lower rates of vaccinations and
higher rates of vaccine-preventable diseases such as whooping cough and measles (Appendix A;
Khazan, 2014).
Since several parents and guardians are opting out of vaccinating their child, herd
immunity is being impacted (Khazan, 2014). When large proportions of community members are
vaccinated against infectious diseases, other members of the community are protected against the
disease because there is a smaller chance of an outbreak through what is coined, herd immunity
(CDC, 2013). Those individuals who may be ineligible for certain vaccines – pregnant women,
infants and immunocomprised individuals – are in turn protected because there is a lower risk of
outbreaks (Appendix B; “Community Immunity,” 2013). Since many counties have lower
numbers of vaccinations, parents are not only negatively impacting their child’s health; they are
risking the health of everyone in their community.
Other reasons why families do not vaccinate their children is due to safety concerns
regarding vaccinations. Parents are fearful of the adverse effects of immunization. In a survey
conducted for the National Consumers League, 1 in 3 parents continue to worry vaccines cause
autism (Yang, 2014). Despite indisputable evidence regarding vaccines not having a relationship
with autism, some parents continue to believe there is a positive relationship between vaccinating
their child and developing autism (Gupta, 2010). Parents who choose not to vaccinate their
children due to the fear of adverse side effects have different vaccine knowledge compared to
those parents who choose to vaccinate (Kennedy, Basket, & Sheedy, 2011).
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Health care providers influence parental vaccination decisions. More than 90% of parents
state they receive vaccine information from their child’s health care provider (Mergler et al.,
2013). Parents trust their health care providers regarding vaccine safety. Providers are the best
source of information for parents regarding the importance of vaccinating their children and the
benefits of full immunization (Grabowsky, Orenstein, & Marcuse, 1996). For many
recommended vaccines, such as the Human Papillomavirus (HPV) vaccine, there are many
missed opportunities of provider recommendation for parents of preteen boys and girls
(Vadaparampil et al., 2011).
Each year, the Information and Education section of the Immunization Branch at the
California Department of Public Health (CDPH) concentrates on increasing immunization rates
in the state of California. This year, the focus of the CDPH is increasing the immunization rate of
HPV among boys and girls. HPV is a common virus in the United States – so common that most
sexually-active men and women will be diagnosed with one type of HPV at some point in their
lifetime (California Department of Public Health [CDPH], 2014). Currently, about 79 million
people are infected with HPV and about 14 million more will become infected every year. Each
year in the United States, roughly 19,000 women and 8,000 men develop HPV-related cancers
(CDC, 2014a). HPV causes cancers of the cervix, vulva, and vagina in women and causes cancer
of the penis in men. HPV can also cause oropharyngeal cancer in both men and women (CDC,
2014b). There are no routine screening methods for HPV-related cancers for men and the only
method available for women is during routine PAP smears and testing for HPV infection. The
HPV vaccine prevents most HPV-related cancers (CDPH, 2014).
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In a recent study, researchers indicated that vaccine-type HPV prevalence has dropped by
56% among 14-19 year old females since the vaccine was introduced in 2006 (Markowitz et al.,
2013). Even though the HPV vaccine is effective and safe, the immunization rates remain low
for adolescents and adults. In 2013, 68% of teen girls in the state of California received ≥1 dose
of HPV vaccine, but only 46% of the teen girls and only 17% of teen boys had completed the
three-dose series (CDC, 2014b). In the same study, vaccination coverage of one dose of the Tdap
vaccine reached 91%; rates of the HPV vaccination would be identical if adolescents received
the HPV vaccine at every given opportunity (Appendix C; Stokley et al., 2014). Missed
vaccinations signify vulnerability to potential HPV-related cancers for preteen boys and girls
(CDPH, 2014).
The CDPH celebrates an annual statewide observance called Preteen Vaccine Week in
the month of February. During this week, the CDPH works with local health departments,
schools, local organizations, immunization coalitions, and primary care providers to increase
awareness of adolescent immunizations and to schedule preteen doctor visits for adolescents to
be immunized against HPV, Tdap (tetanus, diphtheria, whooping cough), meningococcal,
influenza, and second dose of the chickenpox vaccine (CDPH, 2014). With the collaboration of
statewide organizations, the mission of the Information and Education section is to prevent
disease and death due to vaccine-preventable diseases.
The Information and Education section created a Toolkit for Preteen Vaccine Week 2015
which can be found at the link provided. In the Toolkit, state organizations and health care
providers are supplied various tools such as: talking points, media alerts, various print materials,
and activities for organizations to utilize to promote preteen vaccines, especially the HPV
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vaccine. The Toolkit provides organizations around the state with helpful materials regarding
increasing the immunization rates against all Advisory Committee on Immunization Practices
(ACIP) recommendations. The Information and Education section conducts monthly planning
calls with all local health departments and immunization coalitions regarding the Preteen
Vaccine Week campaign and addresses all concerns and issues that may arise during the
planning calls.
The Information and Education section has also developed a Tdap prescription pad (see
Appendix D) in order to vaccinate all women in their third trimester of pregnancy against
whooping cough. In California, children less than 3 months of age have the highest rate of
pertussis-related complications and mortality than other age groups. These infants are too young
to have completed the primary series of pertussis vaccine, and many are too young to have
received one dose of vaccine (CDC, 2014c). Prior studies indicate that parents, most often the
mother, are a common source of pertussis infection to young infants. ACIP and the American
College of Obstetricians and Gynecologists (ACOG) recommend that all women be vaccinated
with pertussis-containing vaccine (Tdap) during the third trimester of every pregnancy.
Currently, in the state of California, estimates of uptake of Tdap vaccine among pregnant women
are below 30% (CDC, 2014d). The approach of shielding infants from pertussis by vaccinating
those individuals in close contact to the infant is known as cocooning. ACIP recommends
cocooning along with maternal Tdap vaccination and childhood DTaP series to best protect
infants from pertussis. However, full cocooning is a challenge so maternal vaccination of Tdap is
the best chance of protecting infants from pertussis (CDC, 2014e).
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The goal of this evaluation is to assess the impact of a written vaccine recommendation
on pertussis immunization receipt by comparing the immunization rates of third trimester
pregnant women in the intervention group using the written recommendation against a control
group using only a verbal recommendation or historic data. The evaluation is currently in
progress, and the CDPH plans to use the findings to determine continued use of the Tdap
prescription pad and inform future development of other materials. Results may be shared with
other statewide partners to help promote the use of the Tdap prescription pad currently being
evaluated. If the pad is proven effective in increasing pertussis immunization rates among
pregnant women, all OB/GYN providers will be provided with prescription pads to recommend
Tdap vaccine in California.
The Information and Education section continues working on various campaigns in hopes
of increasing all vaccination rates in California. Another campaign the section is currently
working on is called Vaccinate Before You Graduate, where parent letters and educational flyers
have been developed for graduating 8th graders and high school seniors. The materials recently
underwent pre- and post-tests to check the efficacy of the message presented and whether the
educational flyers were informative and helpful. Based on the results of the tests, the Information
and Education section will modify the materials and make the materials available on the
California School Nurse Organization (CSNO) website and to all middle and high schools in
California.
The success of all the informational and educational materials the CDPH presents is
measured through annual studies that are conducted regarding vaccination rates, and information
presented through the California Immunization Registry (CAIR). CAIR allows providers storage
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of accurate and confidential information related to immunizations. The registry also helps CDPH
keep track of immunization rates in different regions, target at-risk populations, and can
categorize which vaccines need higher uptake. CAIR helps the Information and Education
section evaluate campaigns and programs they develop by keeping track of who is being
immunized and with which vaccines.
Implementation of the project/methods used
The mission of the fieldwork experience was to assist the Information and Education
section develop materials that can help increase the vaccination rates in the state of California.
This fieldwork practice required the development of educational and informational materials for
statewide organizations, maintain communication with local health departments and primary care
providers, and raise awareness of vaccine-preventable diseases through novel channels, such as
social media messages. The following section of the paper discusses the four goals and learning
objectives of this fieldwork experience.
Methods
General Familiarization with the Immunization Branch of the CDPH
It is important to learn the daily activities of the Information and Education section and
learn the different roles of each staff member. This objective was achieved through the
completion of the orientation training and reviewing all websites and materials of the
Immunization Branch.
Another objective was to observe how the Information and Education section develops
training, education and communication to providers, the general public, local health departments,
partner organizations, and schools, and become a contributing member. This objective was
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achieved by collaborating with various staff members as materials are designed, tested, revised,
and sent through the approvals process. Through participation with team members, campaign
materials were discussed, revised, and tested as required. All developed materials must gain
approval from the entire team before becoming available to statewide organizations.
The third objective for this goal was to expand the knowledge of public health topics.
This was achieved by attending CDPH-Richmond lectures as well as webinars and
familiarization of federal and state immunization programs and policies.
Participate in the planning of Preteen Vaccine Week Campaign 2015
This goal was achieved by learning principles of social marketing campaigns through
participating in planning, design, implementation and evaluation of statewide campaign. By
working alongside Jane Pezua, MPH, the Health Educator and lead developer of the Preteen
Vaccine Week 2015 campaign, campaign materials focusing on the HPV vaccine were
developed and published on the CDPH website so all organizations in California could access the
materials.
Another objective was to assist in the execution of statewide planning calls regarding
Preteen Vaccine Week. This objective was met by participating in planning stages and execution
of statewide conference calls. Every month, planning calls are conducted with local health
departments and immunization coalitions. Prior to all conference calls, planning call slides must
be created with agenda discussing relevant topics and must be e-mailed on the Monday before
the call (see Appendix E for web link for example slides). During all planning calls, participants
were listed by their name and the county they were calling from, and accurate notes and
questions were recorded to be addressed on the following planning call.
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The next objective was to prepare promotional materials to accompany the campaign.
This objective was completed by tracking and evaluating materials created. The materials
developed were: online and print materials, E-blasts, template materials and new media.
PowerPoint presentations were created and presented on the importance of using URL shortners
(Bit.ly and Bit.do) and social media sites to promote vaccinations. Trending Facebook and
Twitter messages were also developed and approved for health care providers and parents to post
and promote Preteen Vaccine Week (see Appendix F for approved social media messages).
Conduct Impact Evaluation on Educational Material
To achieve this goal, the objective of learning how the Immunization Branch responds to
vaccine preventable disease-epidemics (pertussis) and outbreaks must be achieved. To achieve
this objective, it was important to review data, publications, and materials relevant to
Immunization Branch’s tracking of and response to pertussis epidemic in 2014. Different
materials were evaluated from the CDC and ACOG regarding the pertussis epidemic in
California. Studies conducted on the pertussis epidemic were reviewed to learn how to better
promote stronger uptake of the Tdap vaccine.
Additionally, an objective to coordinate with other interns and Immunization Branch staff
on a project testing the impact of a recently developed Information and Education material was
also developed. The Information and Education section developed and tested a prescription pad
of the Tdap vaccine to increase vaccination rates of third trimester pregnant women. An
application was submitted for approval to the Institutional Review Board (IRB) and evaluation
model and methodology was created (see Appendix G). In order to test the prescription pad with
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health care providers, participants had to be recruited in the state of California. This was done by
finding all OB/GYNs in the state of California and calling them to see if they vaccinated for
Tdap on site. If the OB/GYN provider does not vaccinate on the site, they were provided with
information regarding the study and asked to participate. If the provider agreed, packets with
instructions, prescription pads and tracking methods were mailed to their office. Qualitative
surveys were created for the comparison groups for a more thorough study.
Participate in Maintenance of a To Be Determined Immunization Informing Campaign
This goal was achieved by fulfilling the objective of assisting another team member in
the design and promotion of materials promoting immunization. Different educational materials
such as flyers and parent letters were created related to the promotion of immunization. The
materials for the Vaccinate Before You Graduate Campaign were outdated, thus new and
updated versions were developed (see Appendix H). The materials were tested with graduating
8th graders and high school seniors to test efficacy and layout of the materials. The pre- and posttests were developed and presented to participants in community settings (see Appendix I). The
results were presented to the team and revisions of the materials were done as required. The final
materials will be posted on the CSNO website and provided to middle schools and high schools
throughout California once final approval is received.
Results/Findings
The CDPH is an established governmental agency, and the Immunization Branch is
dedicated to improving the rates of immunizations for all individuals in California. The
Information and Education section begins planning for all of the campaigns months in advance.
The staff of the Information and Education section maintains communications via phone and e-
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mail with members from the CDC, health care providers, and organizational partners throughout
the campaign planning. All questions regarding campaign materials and how to best promote
vaccinations are addressed by the Information and Education section. The Information and
Education section maintains close relationships with all of the partners because combating
vaccine-preventable diseases is a group effort.
The campaigns developed through the Information and Education section are successful
because they have one aim: to decrease vaccine-preventable diseases by increasing immunization
rates in statewide. The materials developed are available for everyone to utilize on the CDPH
website and local health agencies can order mass quantities of print materials for no charge.
Materials are developed with cultural and racial variations in mind. Many of the materials
developed by the Information and Education section are translated in Spanish and appropriate
web links are provided on the CDPH website to route individuals from different cultures to
appropriate vaccine-related information.
The Tdap prescription pad evaluation is currently underway so the results are not yet
available. However, through follow-up phone calls and surveys conducted with participating
providers, OB/GYNs provided positive feedbacks regarding increased vaccination rates of third
trimester pregnant women in their respective clinics. After checking in with providers on how
the study is going and whether or not they like utilizing the prescription pad when
recommending the Tdap vaccine to their patients, all of the participating OB/GYNs have stated
that the prescription pads are more effective in recommending the Tdap vaccine to patients than
verbal recommendations alone.
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Application of Results/Public Health Significance

Having a governmental organization partner with local health departments and other
organizations within the state to address vaccination rates is a significant public health project.
Through the development of campaigns and creating Toolkits to help organization increase rates
of vaccinations provides local organizations with guidance of how to better improve vaccination
rates in the state. Vaccines have been proven to save lives, but due to confounding factors the
rates of vaccinations have decreased. By having governmental support from agencies like the
CDPH, providers can be educated on how to stress the importance of recommended vaccines and
local agencies can help educate community members on vaccine safety and regarding the
protection vaccines can provide against deadly communicable diseases.
It is rewarding to ask representatives from all the different counties in California
regarding what information and materials they need to help increase the rates of vaccinations in
their specific counties. Through the monthly planning calls, members of the different counties
are able to request specific educational materials for their counties. For instance, through the
planning calls, members of the Information and Education section were asked to provide a guest
speaker from the CDC to discuss evaluation methods of activities on one of the scheduled
planning calls. Since this was something all participating counties expressed interest in, the
CDPH was able to have two members from the CDC talk about campaign evaluation methods
and metrics (see Appendix J for web link).
Through communicating with immunization coordinators throughout the state, the CDPH
is able to keep track of what the different counties are doing to increase the rates of
immunization in their communities. The campaigns have helped increase awareness of
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immunization in many communities of California, and through the development of different
educational materials, further awareness can spread.
Competencies Addressed
The fieldwork experience has allowed for the incorporation of classroom knowledge to
be applied to real-life public health settings combating real-life public health problems. Through
the fieldwork practice, experience was gained on how to assess the need of communities,
distinguishing stakeholders, creating innovative ways to increase awareness of the public health
problem, and how to track and evaluate measures that are developed to address the problem. The
fieldwork experience has also helped strengthen communication skills between partners to
address the problem and to develop a solution.
Through this fieldwork experience, University of San Francisco (USF) MPH core
competencies and cross-cutting competencies were utilized (see appendix K). Since the goal of
the Information and Education section is to increase the rates of vaccinations among community
members, social and behavioral science core competency was greatly addressed through this
experience because vaccine uptake depends on factors within individuals and communities.
Campaigns and materials are developed to help educate community members regarding the
importance of full vaccination at the individual and community levels. Different activities are
also provided in the Preteen Vaccine Week 2015 Toolkit to help members of the community
become more informed on the importance of being vaccinated against all vaccine-preventable
diseases.
The core competencies of biostatistics and epidemiology were applied when developing
the Tdap prescription pad evaluation study and surveys to increase the Tdap vaccination rates of
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third trimester pregnant women. Data is in the process of being collected and evaluated to
determine whether the created Information and Education material increases Tdap vaccine
uptake. Epidemiology was addressed when monitoring the distribution of decreased vaccination
rates in certain counties of California. Through research, CDPH has a better understanding of
which communities are submitting greater PBEs and where immunization rates remain low.
The environmental health science core knowledge was applied when creating educational
materials in regards to community and social organizations. In reference to the Tdap prescription
pad evaluation, in order for the study to be effective, it was important to find OB/GYN providers
that do not vaccinate for Tdap on site.
One of the important core knowledge that has been shaped and improved throughout the
experience is leadership skills and abilities. For many of the materials developed, the fieldwork
experience provided ample opportunities to step into leadership position and take charge. When
developing and presenting PowerPoint presentations on social media and URL shortners,
creating evaluation plan for the Tdap prescription pad study, submitting documents for approval,
developing certain materials and activities for Preteen Vaccine Week campaign Toolkit, and
updating versions for the Vaccinate Before You Graduate educational materials, all leadership
responsibilities were handed over with minimal supervision.
Along with these core competencies, cross-cutting knowledge areas were also addressed.
The cross-cutting knowledge of health communication and informatics are essential for the
promotion and education of vaccinations. Through effective communication and development of
appropriate health materials, public health professionals are able to change the health beliefs and
behaviors regarding immunization in the communities. Through developing educational
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materials targeted to specific groups of individuals, such as social media messages geared
towards parents and teenagers, community members can help spread awareness of the
importance of being fully vaccinated to other individuals in their social networks.
Program planning is another cross-cutting knowledge that was addressed during this
fieldwork experience. Through determining the needs, planning the materials, and creating an
evaluation plan, appropriate materials are created to address the public health problem. For
instance, since there is a pertussis epidemic in the state of California this year, the need was
addressed by creating a prescription pad providers can use when recommending the Tdap
vaccine to pregnant women in their third trimester of pregnancy. A full evaluation plan was
developed to see whether the prescription pad is effective in increasing vaccination rates among
target population. Providers were recruited based on the requirement of not vaccinating on site
and appropriate materials were sent to the providers to conduct the evaluation.
The final cross-cutting knowledge that was widely addressed was diversity and culture.
Most of the campaign materials that are developed keep cultural beliefs and attitudes in mind.
Most of the materials are also translated into Spanish to help raise awareness of vaccinepreventable diseases in the Hispanic communities of California. The CDPH website has also
been recently updated to direct different ethnic minorities to culturally appropriate websites
regarding vaccine safety information.
The USF MPH program has provided adequate coursework for this fieldwork experience
to be successful. The professors have taught the students to determine the needs of the
community while keeping moral and ethical values in mind. By providing classes focused on
core knowledge areas, students are prepared to enter real public health settings ready to address
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any public health problem. For this fieldwork experience, biostatistics helped develop surveys
and interpret health data, epidemiology helped understand the characteristics of human
population and distribution of vaccination rates, environmental health sciences helped look at
community and social structures, social and behavioral sciences helped develop appropriate
educational materials, and leadership helped build confidence in addressing the public health
need.
Conclusions
This fieldwork experience was extremely enriching and provided immense knowledge of
how to address vital public health problems such as increasing immunization rates in the United
States. The fieldwork was a great experience because it went hand-in-hand with the USF MPH
program. All of the information learned in the classroom was applied in developing materials for
the Information and Education section.
The projects assigned during the fieldwork have helped develop skills such as
communicating and networking with other members to meet a common goal, not being afraid to
ask questions or request clarifications when things may seem unsure, and not being afraid to step
into leadership positions. None of this would have been possible without the support and trust
from the preceptor, Jane Pezua, MPH.
Jane has always been approachable and understanding. She assigned work with
confidence and was always available to help if things were unclear. The fieldwork experience
has helped develop skills and insights of working in the governmental sector of a public health
setting. The combination of courses offered within the MPH program at USF and the public
health fieldwork practice have provided with great experience in understanding a great public
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health need, learning how to build relationships with team members and members of the
community, and developing and evaluating appropriate materials to combat a public health
problem.
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Appendices

Appendix A

This is a map of schools in Santa Monica. The red dots signify schools with severely low rates of
vaccinations.

Appendix B
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Appendix C

Appendix D

Appendix E
Please visit the CDPH Preteen Vaccine Week page (http://bit.do/PlanningSlides) for example of
planning slides created before each planning call.
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Appendix G

Evaluating the effectiveness of a written vaccine recommendation in
improving immunization rates against pertussis in third trimester pregnant
women: Evaluation plan for October – November 2014
Prepared by: Jane Pezua and Vaisali Patel
California Department of Public Health – Immunization Branch
Introduction
In California, children less than three months of age have the highest rate of pertussis-related
complications and mortality than other age groups. These infants are too young to have
completed the primary series of pertussis vaccine; many too young to have even received one
dose of vaccine.
Prior studies have shown parents, most often the mother, are a common source of pertussis
infection to young infants. The Advisory Committee on Immunization Practices and the
American College of Obstetricians and Gynecologists recommend that all women be vaccinated
with pertussis-containing vaccine (Tdap) during the third trimester of each pregnancy, regardless
of whether they have ever received the vaccine previously; however estimates of uptake of Tdap
vaccine among pregnant women are low (below 30%).
Evaluation Goals
The goal of this evaluation is to assess the impact of a written vaccine recommendation on
pertussis immunization receipt by comparing the immunization rates of third trimester pregnant
women in the intervention group using the written recommendation against that of the control
group using only a verbal recommendation/historic data. We plan to use the findings to
determine continued use of the material being evaluated and inform future development of other
materials. Results may be shared with other state partners to help promote the use of the material
being evaluated if proven effective at increasing pertussis immunization rates among pregnant
women.
Evaluation Team
Our team consists of members of the Immunization Branch at the California Department of
Public Health.
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Table 1. Roles and responsibilities of the evaluation team members
Individual
Title/Role
Responsibility
Jane Pezua
Principal Investigator (PI)
• Application for
Determination for Exempt
Research to CPHS
• Recruitment
• Training
• Qualitative survey design
and analysis
• Packaging and mailing of
participant packets
• Data Collection
• Consultation with
EHR/EMR representatives
• Screening of evaluation
study participant
applicants
• Oversight of all evaluation
activities to ensure the
evaluation is conducted as
planned
• Coordinate team meetings
• Presentation of findings
Vaisali Patel
Research Coordinator (RC)
• Application for
Determination for Exempt
Research to CPHS
• Recruitment
• Packaging and mailing of
participants packets
• Data Collection
• Analyze quantitative data
• Ensure implementation of
findings
Steven Smith
Research Coordinator (RC)
• Data collection
• Analyze quantitative data
• Coordinate the analysis of
qualitative data
• Ensure implementation of
findings

I. BACKGROUND AND DESCRIPTION OF THE IMPACT STUDY AND LOGIC
MODEL
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Need
A pertussis epidemic has been declared in the state of California in 2014. Pertussis infection
acquired within the first 3 months of life is frequently severe and fatal. Recently, three infants
have died and many more have been hospitalized. Previous studies have found mothers to be a
common source of pertussis infection in young infants. With a pertussis epidemic declared and
evidence of waning immunity within two years after vaccination with Tdap, immunization of
pregnant women is disappointingly uncommon: a survey of women delivering in California
hospitals in October 2013 indicated that only 20-25% received Tdap during pregnancy. Prenatal
care providers play an important role in preventing additional infant deaths due to pertussis.
As a standard of care, ACOG, ACNM, CDC, and CDPH strongly recommend that all pregnant
women receive Tdap vaccine between 27 and 36 weeks gestation during every pregnancy,
regardless of the number of doses of Tdap they have previously received. Of the infant pertussis
cases reported so far this year (including fatal and hospitalized cases), at least 91% of their
mothers had not received Tdap at the optimal time.
Target Population
The target population for this impact study is pregnant women who were seen by an obstetrician
at a participating practice during the third trimester of pregnancy, however only aggregated totals
of the number of patients presenting for a third trimester appointment and number reporting
receipt of Tdap vaccine on a follow-up visit will be reported to CDPH.
Objectives
The goal of providing prenatal care providers with a Tdap prescription pad is to help providers
communicate a strong recommendation to pregnant women thereby increasing the number of
women receiving the Tdap vaccination during their third trimester of pregnancy. In order to
achieve this overarching goal, objectives were identified for the impact study.
1. There will be an increase of Tdap immunization rates in the intervention group compared
to the control group.
2. More women in their 3rd trimester of pregnancy will receive the Tdap vaccine compared
to baseline data.
3. 50% of OB providers will agree the Tdap prescription pad aided them in providing a
strong recommendation for women to receive the Tdap vaccine in their 3rd trimester of
pregnancy.
Stage of Development
The Tdap prescription pad was developed by the Immunization Branch in 2014. It has been made
available to providers for use in August, 2014.
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Resources/Inputs
Immunization Branch staff and interns (Principal Investigator and two Research Coordinators),
OB physicians, nurses, MAs, office managers, third trimester pregnant women, EHR/EMR
systems and data, Tdap prescription pad, EHR system representative, funds for distribution of
mailers, Tap vaccine, and qualitative surveys of OBs.
Outputs
Print supply of Tdap prescription pads for participating OBs, training of relevant staff at
participating clinics, prescribing of Tdap using the Tdap prescription pad by OBs for 3rd
trimester pregnant women, receipt of Tdap by 3rd trimester pregnant women, reporting of
EHR/EMR generated data to PI and RCs, analysis of aggregate data, completion of qualitative
survey by OBs
Outcomes
A short outcome is to emphasize importance of Tdap in 3rd trimester pregnant women to OBs.
Intermediate outcomes include: increase vaccination rates of 3rd trimester pregnant women and
use evaluation results to determine future promotion of Tdap prescription pad by CDPH. Long
term outcomes include: decrease incidence of pertussis infection in mothers of infants too young
to be vaccinated, decrease incidence of pertussis infection in infants too young to be vaccinated,
and improve effectiveness of Tdap recommendation by OBs to 3rd trimester pregnant women.
Logic Model
Please refer to the Logic Model at the end of the document.
II. FOCUS OF EVALUATION
Evaluation questions
Although the evaluation team produced many questions in a brainstorming session, the
evaluation team arranged the following questions as representing the most important for this
impact study.
To determine if the intervention has been implemented as planned:
•

Have an appropriate number of OB providers been recruited to participate in this study?

To determine if the study is meeting its objectives:
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•

Are OB providers adhering to the utilization of the Tdap prescription pad when
consulting with women in their third trimester of pregnancy?

•

Are OB providers stressing the importance of being vaccinated with Tdap in the third
trimester of pregnancy to prevent pertussis infection in infants?

Evaluation Design
Intervention/control group; analysis of aggregate data. OR intervention group; analysis of pre
and post-intervention data.
III. GATHERING CREDIBLE EVIDENCE: DATA COLLECTION
Data Collection
The evaluation utilizes the following data collection: quantitative aggregate data from
EHR/EMR generated reports on number of third trimester women seen by participating OB
providers and number who later receive Tdap vaccine and qualitative survey administered to
participating OB providers via internet survey (i.e., SurveyMonkey).Table 2 summarizes the data
source and data collection methodology that will be used to gather evidence for the evaluation.
Table 2. Data Collection Plan
Indicator
Number of women who
received the Tdap vaccine
after receiving a prescription

Data Source
Aggregate data from
EHR/EMR system generated
reports

Qualitative survey
administered to OB providers

Internet survey
(SurveyMonkey)

Plan Timeline
Table 3. Illustrative Timeline for Evaluation Activities

Data Collection Method
Review submitted reports
from participating OB
providers on Tdap
immunization of 3rd trimester
pregnant women
• Jane Pezua and Vaisali
Patel
• TBA
Review questions asked and
responses received from
participants
• Jane Pezua & Vaisali
Patel
• TBA
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Evaluation Activities

Timing of Activities for Sep. – Dec. 2014
Sep

Evaluation planning
Data collection
Analysis/interpretation

Oct

Nov

+

+

Dec

+

+

Report/dissemination

+

IV. JUSTIFY CONCLUSIONS: ANALYSIS AND INTERPRETATION
Analysis
We will conduct an observational study to compare the frequency of immunization receipt in the
group offered the prescription pads and the group given only verbal recommendation to
vaccinate. We will use Statistical Analysis System to examine the bivariate relationship between
the two groups. Categorical data will be analyzed for significance using a Chi-square test and
Fisher’s exact test.
It is important to remember that data from all observational studies require attention to reduce
possibility of bias and confounding, given self-selection for vaccination and the influence of
health-seeking behavior.
Table 4. Analysis Plan
Data Analysis Technique

Responsible Person

Quantitative – frequency/counts

Jane Pezua and Vaisali Patel

Qualitative – content analysis

Jane Pezua, Vaisali Patel and
Steven Smith

Interpretation
The PI and the two RCs will be in charge of interpreting the findings. The data from the
evaluation will be compared to the statewide average rates of 3rd trimester women who receive
the Tdap vaccine.
V. ENSURE USE AND SHARE INFORMATION: REPORT AND DISSEMINATION
Dissemination
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Evaluation findings will be disseminated through various routes. Findings will be presented to
the Health Educator Supervisor and Chief of the Information and Education Section of the
Immunization Branch. A summary of findings will be published in the quarterly Immunization
Branch newsletter. The report will be available to the Information and Education staff, different
sections of the Immunization Branch, and participating practices and physicians.
Table 5. Dissemination Plan
Dissemination Medium

Responsible Person

Presentation to Health Educator Supervisor and Jane Pezua
Section Chief, Information and Education
Section, Immunization Branch, CDPH
Report of findings provided to the Information Jane Pezua, Vaisali Patel, and Steven
and Education staff, different sections of the
Smith
Immunization Branch, and participating
practices and physicians
Article in quarterly Immunization Branch
Newsletter

Jane Pezua and Vaisali Patel

Use
The findings from this study will help the Immunization Branch at the CDPH understand how to
better campaign for Tdap immunization of 3rd trimester pregnant women. OB providers will use
the finding to improve patient adherence to recommended vaccinations. Providers will see an
increase in Tdap immunization rates and will use the prescription pad strategy as a means for
effective recommendation of the vaccine. Ultimately, the findings from this evaluation will be
used for future evaluations.
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LOGIC MODEL

Program: Evaluating the effectiveness of a written vaccine recommendation in improving immunization rates against
pertussis in third trimester pregnant women
Situation: Statewide efforts to prevent pertussis infection in infants during pertussis epidemic
Inputs
•
•

•
•
•
•
•
•
•

IZ Branch staff and
interns (PI, 2 RCs)
OB physicians,
nurses/MAs, office
managers
3rd trimester
pregnant women
EHR/EMR systems
and data
Tdap prescription
pad
EHR system
representative
Funds for distribution
of mailers
Tdap vaccine
Qualitative survey of
OBs

•

•

•

•

•

•
•

Assumptions

Outputs
Activities
Print supply of Tdap •
prescription pads for •
participating OBs
•
Training of relevant
•
staff at participating
clinics
Prescribing of Tdap
using the Tdap
prescription pad by
OBs for 3rd trimester
pregnant women
Receipt of Tdap by
3rd trimester
pregnant women
Reporting of
EHR/EMR
generated data to PI
and RCs
Analysis of
aggregate data
Completion of
qualitative survey by
OBs

Participation
3rd trimester women
OB physicians
Nurses/MAs
Office managers

Utilization of Tdap prescription pad by OBs with 3rd trimester pregnant women will result
in higher immunization rates than a verbal recommendation alone.
OBs will provide Tdap prescription to every 3rd trimester pregnant woman seen during
intervention period.

•

Short
Emphasize
importance of Tdap
in 3rd trimester
pregnant women to
OBs

Outcomes -- Impact
Medium
• Increase vaccination
rates of 3rd trimester
pregnant women
• Use evaluation
results to determine
future promotion of
Tdap prescription
pad by CDPH

Long
•

•

•

Decrease incidence
of pertussis
infection in mothers
of infants too young
to be vaccinated
Decrease incidence
of pertussis
infection in infants
too young to be
vaccinated
Improve
effectiveness of
Tdap
recommendation by
OBs to 3rd trimester
pregnant women

External Factors
Inconsistent use of Tdap prescription pad
Influence of media coverage of pertussis epidemic on 3rd trimester pregnant women’s
decision to get vaccinated
Loss of Tdap prescription by 3rd trimester pregnant woman
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Appendix F

Updated high school flyer

Updated 8th grade flyer
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Appendix I

Background Questionnaire
Your initials: ________

Date_________

Please answer all of the questions below. Your answers are confidential and will be used for
research purposes only. Your initials will not appear in any reports.
1. What is your age? __________

2. Your gender?  Male  Female

3. What best describes your racial/ethnic identity?
 White (Non-Latino)
 Asian
 Black
 Latino
 Pacific Islander
 Mixed Race
 Other________________

4. How much do you agree with the following statement? Vaccines are safe and effective.
 Strongly agree  Agree  Neutral  Disagree  Strongly disagree

5. Which of the following shots are recommended before you graduate?
 Tdap
 Meningococcal
 Flu
 HPV
 All of these
(whooping cough)

(human papillomavirus)

6. Who do you think is at risk for getting a vaccine-preventable disease?

7. How much do you agree with the following statement? Do you believe YOU are at risk for
getting a vaccine-preventable disease?
 Strongly agree  Agree  Neutral  Disagree  Strongly disagree
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8. What shots have you received?
 Tdap
 Meningococcal

 HPV

(whooping cough)

 None of these

 Not sure

(human papillomavirus)

9. What have you heard about any of these shots?

10. On a scale of 1 to 5 (1 = not at all important to 5 = critically important)
How important do you think it is for you to protect yourself from vaccine-preventable
diseases by getting the recommended shots?

1

2

3

4

Not Important

5
Critically Important

11. On a scale of 1 to 5, (1 = not at all important to 5 = critically important)
How likely is it that you will ask your parents/guardians and doctor about getting the
recommended shots before you graduate?

1
Not Important

2

3

4

5
Critically Important
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Post-Review Questionnaire

Your initials: ________

Date_________

Now that you have read the flyer, Please answer all of the questions below. Your answers are
confidential and will be used for research purposes only. Your initials will not appear in any
reports.

1. How much do you agree with the following statement? Vaccines are safe and effective.
 Strongly agree  Agree  Neutral  Disagree  Strongly disagree

2. Who do you think is at risk for getting a vaccine-preventable disease?

3. How much do you agree with the following statement? Do you believe YOU are at risk for
getting a vaccine-preventable disease?
 Strongly agree  Agree  Neutral  Disagree  Strongly disagree

4. On a scale of 1 to 5 (1 = not at all important to 5 = critically important)
How important do you think it is for you to protect yourself from vaccine-preventable
diseases by getting the recommended shots?

1

2

3

4

5

Not Important

Critically Important

5. On a scale of 1 to 5, (1 = not at all important to 5 = critically important)
How likely is it that you will ask your parents/guardians and doctor about getting the
recommended shots before you graduate?

1
Not Important

2

3

4

5
Critically Important
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Appendix J
Please take a look at the September Planning Call slides (http://bit.do/SeptemberPlanningCall)
for information regarding evaluation and metrics from guest speakers from the CDC.
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Student Preceptor Agreement

Goal 1: General familiarization with the Immunization Branch of the California Department of Public Health (CDPH)
Objective(s)
Activities
Start/End Date
Who is Responsible
Tracking Measures
Learn the daily activities Complete orientation
August 25, 2014 –
Vaisali Patel and Jane
Jane will give Vaisali a
of the I&E section and
training.
September 5, 2014
Pezua
rundown on the I&E
the different roles of
Review all websites and
section, introduce
each staff member.
materials of
Vaisali to different staff,
Immunization Branch.
and provide trainings.
Collaborate with various August 26, 2014 –
Observe how the
Vasali Patel and Jane
Jane will include Vaisali
staff members as
Information and
November 26, 2014
Pezua
in all of the meetings
Education (I&E) section materials are designed,
and assign Vaisali to
develops training,
tested, revised, and sent
work on specific
through the approvals
education and
projects.
communication to
process.
providers, the general
Participate in I&E health
public, local health
education team
meetings.
departments, partner
organizations, and
schools, and become a
contributing member.
Expand knowledge of
Attend CDPHAugust 25, 2014 –
Vaisali Patel
Vaisali will attend all
public health related
Richmond lectures.
November 26, 2014
relevant lectures and
topics.
Familiarization of
seminars presented at the
federal and state
CDPH and will, through
immunization programs
her assignment to
and policies.
various projects,
research federal and
state immunization
programs and the
vaccine policy process.
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Goal 2: Goal: Participate in Planning of Preteen Vaccine Week Campaign 2015, an immunization informing campaign
Objective(s)
Activities
Start/End Date
Who is Responsible
Tracking Measures
Learn principles of
Participate in planning,
August 20, 2014 –
Vaisali Patel and Jane
Jane and Vaisali will
social marketing
design, implementation
November 26, 2014
Pezua
work together to create
campaigns.
and evaluation of
the campaign materials
statewide campaign.
for Preteen Vaccine
Week 2015; focusing on
the HPV vaccine.
Assist in the execution
Participate in planning
August 20, 2014 –
Vasali Patel and Jane
Jane will include Vaisali
of statewide planning
stages and execution of
November 26, 2014
Pezua
in the conference calls.
calls.
statewide conference
calls.
Prepare promotional
Track and evaluate
August 26, 2014 –
Vaisali Patel and Jane
Vaisali will help Jane
materials to accompany through materials
November 26, 2014
Pezua
create educational
campaign.
created:
material for Preteen
Online/print
Vaccine Week 2015.
materials, E-blasts,
Jane and Vaisali will
template materials, new
evaluate new materials
media.
and revise as necessary.
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Goal 3: Goal: Conduct Impact Evaluation of Education Material
Objective(s)
Activities
Start/End Date
Learn how the
Review data,
September 2, 2014 –
Immunization Branch
publications, and
November 26, 2014
responds to vaccine
materials relevant to
preventable diseaseImmunization Branch’s
epidemics (pertussis)
tracking of and response
and outbreaks.
to pertussis epidemic
2014.
Coordinate with other
interns and IZ Branch
Staff on a project testing
the impact of a recently
develop I&E material.

Design evaluation model September 2, 2014 –
and methodology.
November 26, 2014
Recruit and train
participants at health
clinics.

Who is Responsible
Vaisali Patel and Jane
Pezua

Tracking Measures
Jane will provide Vaisali
with data and materials
to review on the
pertussis epidemic in
2014.

Vasali Patel and Jane
Pezua

Vaisali will work with
Jane to design evaluation
model and help recruit
and train participants in
health clinics in Los
Angeles county.

Goal 4: Goal: Participate in maintenance of a TBD immunization informing campaign
Objective(s)
Activities
Start/End Date
Who is Responsible
Assist in the design and Create educational
September 2, 2014 –
Rebeca Boyte, MAS
promotion of materials
material such as banners October 3, 2014
(Health Education
promoting
and posters related to the
Supervisor) and Vaisali
immunization.
promotion of
Patel
immunization.

Tracking Measures
Vaisali will work with
Rebeca to revise and
update educational
material for the assigned
campaign.

